Cargando…
The Del1 deposition domain can immobilize 3α-hydroxysteroid dehydrogenase in the extracellular matrix without interfering with enzymatic activity
Developing methods that result in targeting of therapeutic molecules in gene therapies to target tissues has importance, as targeting can increase efficacy and decrease off target-side-effects. Work from my laboratory previously showed that the extracellular matrix protein Del1 is organized in the e...
Autores principales: | Hidai, Chiaki, Kitano, Hisataka, Kokubun, Shinichiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714445/ https://www.ncbi.nlm.nih.gov/pubmed/19018576 http://dx.doi.org/10.1007/s00449-008-0278-5 |
Ejemplares similares
-
The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis
por: Ishikawa, Tomomi, et al.
Publicado: (2016) -
Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors
por: Kitano, Hisataka, et al.
Publicado: (2016) -
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA
por: Kitano, Hisataka, et al.
Publicado: (2022) -
Nonviral Gene Therapy for Cancer: A Review
por: Hidai, Chiaki, et al.
Publicado: (2018) -
Dimerization and enzymatic activity of fungal 17β-hydroxysteroid dehydrogenase from the short-chain dehydrogenase/reductase superfamily
por: Kristan, Katja, et al.
Publicado: (2005)